Belimumab 10 mg/kg
Belimumab 10 mg/kg is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy
Belimumab in Remission of VASculitis
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States
Clinical Trials (9)
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy
Belimumab in Remission of VASculitis
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9